The effect of a promoter polymorphism on the transcription of nitric oxide synthase 1 and its relevance to Parkinson's disease

Journal of Neuroscience Research

Volumn 87, Issue 10, 2009, Pages 2319-2325

  Rife, Terrie ^a   Rasoul, Bareza ^a   Pullen, Nicholas ^a   Mitchell, David ^a   Grathwol, Kristen ^a   Kurth, Janice ^b  

^a JAMES MADISON UNIVERSITY   (United States)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Chromatin; DNA sequences; Interaction with regulatory proteins; Transcription regulation

Indexed keywords

NEURONAL NITRIC OXIDE SYNTHASE; NOS1 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HELA CELL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NEUROBLASTOMA CELL; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION; UPREGULATION; AGED; CASE CONTROL STUDY; FEMALE; GENETIC PREDISPOSITION; GENETIC TRANSFECTION; GENETICS; MALE; METHODOLOGY; REGULATORY SEQUENCE;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HELA CELLS; HUMANS; MALE; NITRIC OXIDE SYNTHASE TYPE I; PARKINSON DISEASE; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; REGULATORY SEQUENCES, NUCLEIC ACID; TRANSFECTION;

EID: 69249221597     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22045     Document Type: Article

References (35)

1. Agarwal AK, Giacchetti G, Lavery G, Nikkila H, Palermo M, Ricketts M, McTernan C, Bianchi G, Manunta P, Strazzullo P, Mantero F, White PC, Stewart PM. 2000. CA-Repeat polymorphism in intron 1 of HSD11B2: effects on gene expression and salt sensitivity. Hypertension 36:187-194.
2. Antunes F, Han D, Rettori D, Cadenas E. 2002. Mitochondrial damage by nitric oxide is potentiated by dopamine in PC12 cells. Biochim Biophys Acta 1556:233-238.
3. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
4. Brahmachari SK, Meera G, Sarkar PS, Balagurumoorthy P, Tripathi J, Raghavan S, Shaligram U, Pataskar S. 1995. Simple repetitive sequences in the genome: structure and functional significance. Electrophoresis 16:1705-1714.
5. Bros M, Boissel JP, Godtel-Armbrust U, Forstermann U. 2006. Transcription of human neuronal nitric oxide synthase mRNAs derived from different first exons is partly controlled by exon 1-specific promoter sequences. Genomics 87:463-473.
6. Carbone DL, Moreno JA, Tjalkens RB. 2008. Nuclear factor kappa-B mediates selective induction of neuronal nitric oxide synthase in astrocytes during low-level inflammatory stimulation with MPTP. Brain Res 1217:1-9.
7. Chiueh CC, Andoh T, Lai AR, Lai E, Krishna G. 2000. Neuroprotective strategies in Parkinson's disease: protection against progressive nigral damage induced by free radicals. Neurotox Res 2:293-310.
8. Chung KK, Thomas B, Li X, Pletnikova O, Troncoso JC, Marsh L, Dawson VL, Dawson TM. 2004. S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science 304:1328-1331.
9. Deans Z, Dawson SJ, Xie J, Young AP, Wallace D, Latchman DS. 1996. Differential regulation of the two neuronal nitric-oxide synthase gene promoters by the Oct-2 transcription factor. J Biol Chem 271:32153-32158.
10. Eve DJ, Nisbet AP, Kingsbury AE, Hewson EL, Daniel SE, Lees AJ, Marsden CD, Foster OJ. 1998. Basal ganglia neuronal nitric oxide synthase mRNA expression in Parkinson's disease. Brain Res Mol Brain Res 63:62-71.
11. Fang J, Nakamura T, Cho DH, Gu Z, Lipton SA. 2007. S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson's disease. Proc Natl Acad Sci U S A 104:18742-18747.
12. Galimberti D, Scarpini E, Venturelli E, Strobel A, Herterich S, Fenoglio C, Guidi I, Scalabrini D, Cortini F, Bresolin N, Lesch KP, Reif A. 2008. Association of a NOS1 promoter repeat with Alzheimer's disease. Neurobiol Aging 29:1359-1365.
13. Gatto EM, Riobo NA, Carreras MC, Chernavsky A, Rubio A, Satz ML, Poderoso JJ. 2000. Overexpression of neutrophil neuronal nitric oxide synthase in Parkinson's disease. Nitric Oxide 4:534-539.
14. Hall AV, Antoniou H, Wang Y, Cheung AH, Arbus AM, Olson SL, Lu WC, Kau CL, Marsden PA. 1994. Structural organization of the human neuronal nitric oxide synthase gene (NOS1). J Biol Chem 269:33082-33090.
15. Hunot S, Boissiere F, Faucheux B, Brugg B, Mouatt-Prigent A, Agid Y, Hirsch EC. 1996. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience 72:355-363.
16. Itzhak Y, Ali SF. 1996. The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo. J Neurochem 67:1770-1773.
17. Johnson WG. 1991. Genetic susceptibility to Parkinson's disease. Neurology 41:82-87.
18. Johnson MP, Lea RA, Colson NJ, Macmillan JC, Griffiths LR. 2005. A population genomics overview of the neuronal nitric oxide synthase (nNOS) gene and its relationship to migraine susceptibility. Cell Mol Biol (Noisy-Le-Grand) 51:285-292.
19. Kurth JH, Kurth MC, Poduslo SE, Schwankhaus JD. 1993. Association of a monoamine oxidase B allele with Parkinson's disease. Ann Neurol 33:368-372.
20. Langston JW, Widner H, Goetz CG, Brooks D, Fahn S, Freeman T, Watts R. 1992. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 7:2-13.
21. Lo HS, Hogan EL, Soong BW. 2002. 5′-flanking region polymorphism of the neuronal nitric oxide synthase gene with Parkinson's disease in Taiwan. J Neurol Sci 194:11-13.
22. Nordheim A, Rich A. 1983. The sequence (dC-dA)n X (dG-dT)n forms left-handed Z-DNA in negatively supercoiled plasmids. Proc Natl Acad Sci U S A 80:1821-1825.
23. Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ, Hutchinson IV. 1999. In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet 26:1-3.
24. Reif A, Herterich S, Strobel A, Ehlis AC, Saur D, Jacob CP, Wienker T, Topner T, Fritzen S, Walter U, Schmitt A, Fallgatter AJ, Lesch KP. 2006. A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Mol Psychiatry 11:286-300.
25. Rife TK, Xie J, Redman C, Young AP. 2000. The 5′2 promoter of the neuronal nitric oxide synthase dual promoter complex mediates inducibility by nerve growth factor. Brain Res Mol Brain Res 75:225-236.
26. Rothenburg S, Koch-Nolte F, Haag F. 2001. DNA methylation and Z-DNA formation as mediators of quantitative differences in the expression of alleles. Immunol Rev 184:286-298.
27. Salum C. 2008. Modulation of dopamine uptake by nitric oxide in cultured mesencephalic neurons. Brain Res 1198:27-33.
28. Sham PC, Curtis D. 1995. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 59:97-105.
29. Shang T, Kotamraju S, Kalivendi SV, Hillard CJ, Kalyanaraman B. 2004. 1-Methyl-4-phenylpyridinium-induced apoptosis in cerebellar granule neurons is mediated by transferrin receptor iron-dependent depletion of tetrahydrobiopterin and neuronal nitric-oxide synthase-derived superoxide. J Biol Chem 279:19099-19112.
30. Sharma VK, Kumar N, Brahmachari SK, Ramachandran S. 2007. Abundance of dinucleotide repeats and gene expression are inversely correlated: a role for gene function in addition to intron length. Physiol Genomics 31:96-103.
31. Shimajiri S, Arima N, Tanimoto A, Murata Y, Hamada T, Wang KY, Sasaguri Y. 1999. Shortened microsatellite d(CA)21 sequence down-regulates promoter activity of matrix metalloproteinase 9 gene. FEBS Lett 455:70-74.
32. Tajouri L, Ferreira L, Ovcaric M, Curtain R, Lea R, Csurhes P, Pender MP, Griffiths LR. 2004. Investigation of a neuronal nitric oxide synthase gene (NOS1) polymorphism in a multiple sclerosis population. J Neurol Sci 218:25-28.
33. Texereau J, Marullo S, Hubert D, Coste J, Dusser DJ, Dall'Ava-Santucci J, Dinh-Xuan AT. 2004. Nitric oxide synthase 1 as a potential modifier gene of decline in lung function in patients with cystic fibrosis. Thorax 59:156-158.
34. Vasudevaraju P, Bharathi, Garruto RM, Sambamurti K, Rao KS. 2008. Role of DNA dynamics in Alzheimer's disease. Brain Res Rev 58:136-148.
35. Xie J, Roddy P, Rife TK, Murad F, Young AP. 1995. Two closely linked but separable promoters for human neuronal nitric oxide synthase gene transcription. Proc Natl Acad Sci U S A 92:1242-1246.